WuXi AppTec Co., Ltd. (HKG:2359)

Market Cap	209.27B
Revenue (ttm)	40.35B
Net Income (ttm)	10.06B
Shares Out	n/a
EPS (ttm)	2.90
PE Ratio	20.81
Forward PE	n/a
Dividend	1.09 (1.58%)
Ex-Dividend Date	May 8, 2025

Volume	10,424,318
Average Volume	6,972,765
Open	66.90
Previous Close	66.90
Day's Range	66.30 - 70.70
52-Week Range	27.50 - 76.00
Beta	0.89
RSI	61.43
Earnings Date	Mar 18, 2025

About WuXi AppTec

WuXi AppTec Co., Ltd., an investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs and advanced therapies in the People’s Republic of China, the United States, Europe, and internationally. The company operates in six segments: WuXi Chemistry, WuXi Testing, WuXi Biology, WuXi ATU, WuXi DDSU, and Others. It offers contract research, development, and manufacturing organization services for new drug development from discovery to commercial covering various categ...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 2000
• Employees: 41,116
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 2359

Financial Performance

In 2024, WuXi AppTec's revenue was 37.92 billion, a decrease of -1.97% compared to the previous year's 38.68 billion. Earnings were 9.45 billion, a decrease of -1.63%.

Financial numbers in CNY